Initial research are generating significant interest surrounding the new drug , a promising dual compound targeting GLP-1 and glucose-dependent insulinotropic polypeptide. Compared to existing slimming therapies , retatrutide seems to deliver greater reductions in body fat and enhance insulin health in preliminary tests . Although additional… Read More